1. Home
  2. SNGX vs MGOL Comparison

SNGX vs MGOL Comparison

Compare SNGX & MGOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • MGOL
  • Stock Information
  • Founded
  • SNGX 1987
  • MGOL 2018
  • Country
  • SNGX United States
  • MGOL United States
  • Employees
  • SNGX N/A
  • MGOL N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • MGOL Advertising
  • Sector
  • SNGX Health Care
  • MGOL Consumer Discretionary
  • Exchange
  • SNGX Nasdaq
  • MGOL Nasdaq
  • Market Cap
  • SNGX 7.4M
  • MGOL 7.3M
  • IPO Year
  • SNGX 1987
  • MGOL 2023
  • Fundamental
  • Price
  • SNGX $2.35
  • MGOL $0.58
  • Analyst Decision
  • SNGX
  • MGOL
  • Analyst Count
  • SNGX 0
  • MGOL 0
  • Target Price
  • SNGX N/A
  • MGOL N/A
  • AVG Volume (30 Days)
  • SNGX 619.7K
  • MGOL 6.0M
  • Earning Date
  • SNGX 03-14-2025
  • MGOL 11-14-2024
  • Dividend Yield
  • SNGX N/A
  • MGOL N/A
  • EPS Growth
  • SNGX N/A
  • MGOL N/A
  • EPS
  • SNGX N/A
  • MGOL N/A
  • Revenue
  • SNGX $364,183.00
  • MGOL $5,197,527.00
  • Revenue This Year
  • SNGX N/A
  • MGOL N/A
  • Revenue Next Year
  • SNGX $76.64
  • MGOL N/A
  • P/E Ratio
  • SNGX N/A
  • MGOL N/A
  • Revenue Growth
  • SNGX N/A
  • MGOL 47.01
  • 52 Week Low
  • SNGX $1.83
  • MGOL $0.36
  • 52 Week High
  • SNGX $14.88
  • MGOL $18.30
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 34.04
  • MGOL 26.07
  • Support Level
  • SNGX $2.03
  • MGOL $0.51
  • Resistance Level
  • SNGX $3.44
  • MGOL $0.66
  • Average True Range (ATR)
  • SNGX 0.33
  • MGOL 0.11
  • MACD
  • SNGX -0.08
  • MGOL 0.06
  • Stochastic Oscillator
  • SNGX 19.39
  • MGOL 37.75

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About MGOL MGO Global Inc.

MGO Global Inc has built a brand acceleration platform with a focus on the acquisition, optimization and monetization of consumer brands across multiple categories. Its mission is to provide customers with unmatched variety, quality and shopping experience. The Company has three reportable segments: 1) The Messi Store, which sells a range of products under The Messi Brand; 2) Stand Flagpoles, which sells a range of residential flagpoles and related products direct to consumers; and 3) Corporate, which generates no revenue, but reflects corporate expenses related primarily to being a public company.

Share on Social Networks: